Juan M. E. Harrison

Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.

Transport Corporation of America, Inc. provides a wide range of truckload carriage and logistics services. It provides satellite-based communications with the fleet. The company was founded in 1984 and is headquartered in Eagan, MS.

Union Carbide Corp. engages in the production of chemicals and polymers. The firm operates through the following geographical segments: United States, Asia Pacific and Rest of the World. Its products include polyethylene and polypropylene, ethylene glycol, isopropanol, ethyleneamines, biocides, surfactants, deicing and anti-icing fluids, amines, solution vinyl resins and polyethylene glycols. The company was founded on November 1, 1917 and is headquartered in Seadrift, TX.

Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI.

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC.

Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA.

Kenet, Inc. designs semiconductor devices. The company was founded by Michael P. Anthony, John C.C. Fan, Paul J. Mitchellin and Gerhard Sollner in April 2002 and is headquartered in Milpitas, CA.

Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ.

Icagen, Inc. engages in the development of pharmaceutical and drug discovery instruments. It offers chemistry, biology, and ion channels and transporters. The company was founded by Benjamin P. Warner and Frank Jeremiel Zimmerman in 1992 and is headquartered in Durham, NC.

Chondrial Therapeutics, Inc. operates as a biotechnology company which focuses on the treatment of rare mitochondrial diseases. Its compound is CTI-1601, which the company is developing as a potential treatment for Friedreich’s Ataxia. The company was founded by Steven R. Plump and Mark R. Payne and is headquartered in Bala Cynwyd, PA.

Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY.

The Jackson Laboratory provides biotechnology research services. It offers nonprofit research, biomedical research, genomics, genetics, cancer, neuroscience, immunology, aging, bioinformatics, computational biology, research mice, genomic medicine, reproductive biology, developmental biology, eye research and hearing research. The company was founded by Clarence Cook Little in 1929 and is headquartered in Bar Harbor, ME.

The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States.

Caliper Technologies Corp. is a leading provider of microfluidic technology and laboratory automation solutions. The private company is based in Mountain View, CA. The company serves a broad range of markets in the worldwide life science, biotechnology, and pharmaceutical industries. The company was founded by J. Michael Ramsey.

Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.

VR Management LLC specializes in capital investment focuses on technology and health care sectors. The company is headquartered in Palo Alto, CA.

New York Genome Center operates as an independent, nonprofit academic research institution that provides genomic research. It provides research on neurodegenerative disease, neuropsychiatric disease, and cancer. The company was founded in 2011 and is headquartered in New York, NY.

Deerfield Management Co. LP (Private Equity) (Deerfield) is a private equity subsidiary of Deerfield Management Co. LP founded in 1994. The firm is headquartered in the New York.

Vescor LLC, engages in the discovery and development autophagy targeted therapeutics for cancer treatment. The firm develops small molecule inhibitors of a number of protein targets at critical nodes of the autophagy cascade, perform investigational new drug (IND) enabling studies, and move these into clinical development. The company was founded by Eileen White and Alec Kimmelman and is headquartered in New York, NY.

Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY.

Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN.

Chondrial Therapeutics Holdings LLC engages in operation of a biotechnology firm. The company was founded in 2016 and is headquartered in Bala Cynwyd, PA.

Memorial Sloan-Kettering Cancer Center (Investment Management) (MSK-IM) is the investment management division of Memorial Sloan-Kettering Cancer Center, a non-profit organization headquartered in New York City. The firm was formed in 1960 to coordinate and guide the overall policy for Memorial Hospital and the Sloan Kettering Institute, and in 1980 these entities were unified into a single institution, with a single president and CEO. MSK-IM manages the investment portfolio of MSK.

Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million.